Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response
The heterogeneity of breast cancer has a major role in drug response and resistance. In this study, the authors use patient-derived tumour xenografts as a platform for drug testing and correlation with single-cell proteomic phenotypes characterized by mass cytometry.
Guardado en:
Autores principales: | Dimitra Georgopoulou, Maurizio Callari, Oscar M. Rueda, Abigail Shea, Alistair Martin, Agnese Giovannetti, Fatime Qosaj, Ali Dariush, Suet-Feung Chin, Larissa S. Carnevalli, Elena Provenzano, Wendy Greenwood, Giulia Lerda, Elham Esmaeilishirazifard, Martin O’Reilly, Violeta Serra, Dario Bressan, IMAXT Consortium, Gordon B. Mills, H. Raza Ali, Sabina S. Cosulich, Gregory J. Hannon, Alejandra Bruna, Carlos Caldas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70db0dc523da4d5ab06795129ce34559 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.
por: Bruna Victorasso Jardim-Perassi, et al.
Publicado: (2014) -
El derecho al trabajo decente de las personas con discapacidades
por: O'Reilly, Arthur
Publicado: (2003) -
Targeted therapy of human leukemia xenografts in immunodeficient zebrafish
por: Ranganatha R. Somasagara, et al.
Publicado: (2021) -
Next-generation sequence analysis of cancer xenograft models.
por: Fernando J Rossello, et al.
Publicado: (2013) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Sofia Karkampouna, et al.
Publicado: (2021)